A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1 (HRS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01373606
Recruitment Status : Completed
First Posted : June 15, 2011
Last Update Posted : February 14, 2012
Information provided by (Responsible Party):
Ferring Pharmaceuticals